Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01VQM
|
|||
| Former ID |
DIB002163
|
|||
| Drug Name |
CHR-5154
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Phase 1 | [1] | |
| Company |
Chroma Therapeutics Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01934101) Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.